The present study identified that treatment with AA was able to induce hepatic Smad7, thereby blocking TGF-beta/Smad signaling and fibrosis in a rat model of CCl4-induced liver fibrosis and in TGF-beta1-activated HSC in vitro. Here, SMAD7 is linked to Hepatic fibrosis.